The development and initial validation of IgG4-related disease damage index: a consensus report from Chinese IgG4-RD Consortium.
Linyi PengJingna LiJiaxin ZhouYunyun FeiLingli DongYan-Ying LiuDingding ZhangYanhong WangShuhong ChiFang WangYunxia HouXiaoping HongHongsheng SunYujin YeNan CheRong ZhangChangyan LiuZongfei JiWenjia SunCheng ZhaoNing MaYamin LaiMeng Tao LiYan ZhaoXiaofeng ZengLiwei LuWen Zhangnull nullPublished in: RMD open (2024)
The IgG4-RD DI is a useful approach to analyse disease outcomes, and it has good operability and credibility. It is anticipated that the DI will become a useful tool for therapeutic trials and studies of prognosis in patients with IgG4-RD.